OrthoPediatrics (KIDS) announced the FDA approval of its 3P Pediatric Plating Platform Small-Mini System, the second of several systems in the 3P family. This represents the company’s sixth FDA approval in 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- KIDS Upcoming Earnings Report: What to Expect?
- OrthoPediatrics price target lowered to $34 from $37 at Lake Street
- OrthoPediatrics price target lowered to $18 from $22 at Truist
- OrthoPediatrics price target lowered to $23 from $39 at BTIG
- OrthoPediatrics price target lowered to $25 from $35 at Citizens JMP